Examining the use of sodium nitroprusside in coronary artery bypass grafting

Is the benefit worth the cost?

Caitlin Marie Gibson, Sondra Davis, Darien Bradford

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Purpose: Sodium nitroprusside is a vasodilator frequently used in the coronary artery bypass grafting (CABG) setting. However, the price of a 50-mg vial of sodium nitroprusside increased from $5.00 in 2003 to up to $900 in 2016. The purpose of this review is to help health systems balance high-quality patient care with economic responsibility. Methods: A MEDLINE literature search was performed using the search terms "nitroprusside" and "coronary artery bypass." All English-language trials in human subjects assessing the use of sodium nitroprusside in the setting of CABG were evaluated. The references of these studies were also reviewed. Results: In the setting of CABG, sodium nitroprusside attenuates conduit vasospasm and reduces the incidence of inflammation, atrial fibrillation, and acute kidney injury after surgery. However, other vasodilators are more effective at maintaining postoperative blood pressure at goal. Conclusions: Despite its cost, sodium nitroprusside may be an appropriate agent to use during CABG operations, but other agents should be considered for treatment of postoperative hypertension.

Original languageEnglish
Pages (from-to)502-507
Number of pages6
JournalHospital Pharmacy
Volume52
Issue number7
DOIs
StatePublished - 1 Jul 2017

Fingerprint

Nitroprusside
Coronary Artery Bypass
Cost-Benefit Analysis
Costs
Vasodilator Agents
Quality of Health Care
Blood pressure
Acute Kidney Injury
MEDLINE
Atrial Fibrillation
Surgery
Patient Care
Language
Economics
Health
Blood Pressure
Hypertension
Inflammation
Costs and Cost Analysis
Incidence

Keywords

  • CABG
  • Coronary artery bypass
  • Postoperative atrial fibrillation
  • Postoperative hypertension
  • Sodium nitroprusside
  • Vasodilators

Cite this

@article{1abf5e14fa0048fc81d1fa8333d0fd42,
title = "Examining the use of sodium nitroprusside in coronary artery bypass grafting: Is the benefit worth the cost?",
abstract = "Purpose: Sodium nitroprusside is a vasodilator frequently used in the coronary artery bypass grafting (CABG) setting. However, the price of a 50-mg vial of sodium nitroprusside increased from $5.00 in 2003 to up to $900 in 2016. The purpose of this review is to help health systems balance high-quality patient care with economic responsibility. Methods: A MEDLINE literature search was performed using the search terms {"}nitroprusside{"} and {"}coronary artery bypass.{"} All English-language trials in human subjects assessing the use of sodium nitroprusside in the setting of CABG were evaluated. The references of these studies were also reviewed. Results: In the setting of CABG, sodium nitroprusside attenuates conduit vasospasm and reduces the incidence of inflammation, atrial fibrillation, and acute kidney injury after surgery. However, other vasodilators are more effective at maintaining postoperative blood pressure at goal. Conclusions: Despite its cost, sodium nitroprusside may be an appropriate agent to use during CABG operations, but other agents should be considered for treatment of postoperative hypertension.",
keywords = "CABG, Coronary artery bypass, Postoperative atrial fibrillation, Postoperative hypertension, Sodium nitroprusside, Vasodilators",
author = "Gibson, {Caitlin Marie} and Sondra Davis and Darien Bradford",
year = "2017",
month = "7",
day = "1",
doi = "10.1177/0018578717722538",
language = "English",
volume = "52",
pages = "502--507",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Thomas Land Publishers Inc.",
number = "7",

}

Examining the use of sodium nitroprusside in coronary artery bypass grafting : Is the benefit worth the cost? / Gibson, Caitlin Marie; Davis, Sondra; Bradford, Darien.

In: Hospital Pharmacy, Vol. 52, No. 7, 01.07.2017, p. 502-507.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Examining the use of sodium nitroprusside in coronary artery bypass grafting

T2 - Is the benefit worth the cost?

AU - Gibson, Caitlin Marie

AU - Davis, Sondra

AU - Bradford, Darien

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Purpose: Sodium nitroprusside is a vasodilator frequently used in the coronary artery bypass grafting (CABG) setting. However, the price of a 50-mg vial of sodium nitroprusside increased from $5.00 in 2003 to up to $900 in 2016. The purpose of this review is to help health systems balance high-quality patient care with economic responsibility. Methods: A MEDLINE literature search was performed using the search terms "nitroprusside" and "coronary artery bypass." All English-language trials in human subjects assessing the use of sodium nitroprusside in the setting of CABG were evaluated. The references of these studies were also reviewed. Results: In the setting of CABG, sodium nitroprusside attenuates conduit vasospasm and reduces the incidence of inflammation, atrial fibrillation, and acute kidney injury after surgery. However, other vasodilators are more effective at maintaining postoperative blood pressure at goal. Conclusions: Despite its cost, sodium nitroprusside may be an appropriate agent to use during CABG operations, but other agents should be considered for treatment of postoperative hypertension.

AB - Purpose: Sodium nitroprusside is a vasodilator frequently used in the coronary artery bypass grafting (CABG) setting. However, the price of a 50-mg vial of sodium nitroprusside increased from $5.00 in 2003 to up to $900 in 2016. The purpose of this review is to help health systems balance high-quality patient care with economic responsibility. Methods: A MEDLINE literature search was performed using the search terms "nitroprusside" and "coronary artery bypass." All English-language trials in human subjects assessing the use of sodium nitroprusside in the setting of CABG were evaluated. The references of these studies were also reviewed. Results: In the setting of CABG, sodium nitroprusside attenuates conduit vasospasm and reduces the incidence of inflammation, atrial fibrillation, and acute kidney injury after surgery. However, other vasodilators are more effective at maintaining postoperative blood pressure at goal. Conclusions: Despite its cost, sodium nitroprusside may be an appropriate agent to use during CABG operations, but other agents should be considered for treatment of postoperative hypertension.

KW - CABG

KW - Coronary artery bypass

KW - Postoperative atrial fibrillation

KW - Postoperative hypertension

KW - Sodium nitroprusside

KW - Vasodilators

UR - http://www.scopus.com/inward/record.url?scp=85032456371&partnerID=8YFLogxK

U2 - 10.1177/0018578717722538

DO - 10.1177/0018578717722538

M3 - Article

VL - 52

SP - 502

EP - 507

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 7

ER -